Catalyst Capital Advisors LLC Novartis Ag Transaction History

Catalyst Capital Advisors LLC

$4.3 Billion
Q2 2024

A detailed history of Catalyst Capital Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 27,518 shares of NVS stock, worth $3.04 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

27,518

Previous 27,518 -0.0%

Holding current value

$3.04 Million

Previous $2.66 Million 10.07%

% of portfolio

0.07%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $717,200 - $795,939	-7,571 Reduced 21.58%	27,518 $2.8 Million
Q2 2023 Aug 08, 2023	SELL	$92.52 - $104.91 $416,340 - $472,095	-4,500 Reduced 11.37%	35,089 $3.54 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $79,309 - $91,974	-991 Reduced 2.44%	39,589 $3.64 Million
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $151,100 - $185,040	-2,000 Reduced 4.7%	40,580 $3.68 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $200,275 - $226,550	2,500 Added 6.24%	42,580 $3.74 Million
Q4 2021 Feb 10, 2022	BUY	$79.7 - $88.13 $239,100 - $264,390	3,000 Added 8.09%	40,080 $3.51 Million
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $89,958 - $104,654	-1,100 Reduced 2.88%	37,080 $3.03 Million
Q2 2021 Aug 06, 2021	BUY	$85.24 - $94.15 $263,221 - $290,735	3,088 Added 8.8%	38,180 $3.48 Million
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $18,537 - $21,860	222 Added 0.64%	35,092 $3 Million
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $126,852 - $177,722	1,795 Added 5.43%	34,870 $2.88 Million
Q2 2019 Aug 08, 2019	BUY	$75.4 - $92.8 $452,400 - $556,800	6,000 Added 22.16%	33,075 $3.02 Million
Q1 2019 May 08, 2019	BUY	$75.32 - $86.15 $150,640 - $172,300	2,000 Added 7.98%	27,075 $2.6 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $1.86 Million - $1.94 Million	25,075	25,075 $2.15 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Novartis Ag Transaction History